Management of HIV-associated esophageal disease.
Belitsos
P C
PC
Johns Hopkins University, AIDS Service, Baltimore, MD.
D000935:Antifungal Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002177:Candidiasis / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D003680:Deglutition Disorders / Q000150:complications / Q000628:therapy; D004935:Esophageal Diseases / Q000150:complications / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D004938:Esophageal Neoplasms / Q000150:complications / Q000628:therapy; D015774:Ganciclovir / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology / Q000628:therapy; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000628:therapy; D014456:Ulcer / Q000150:complications / Q000628:therapy
D000935:Antifungal Agents; D015774:Ganciclovir